Login / Signup

Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial.

Jun-Hyung ChoSo-Young JinSu-Yeon Park
Published in: Expert review of anti-infective therapy (2021)
Clinical trial registration: www.clinicaltrials.gov identifier is NCT05002595.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • clinical trial
  • phase ii
  • open label
  • study protocol
  • stem cells
  • randomized controlled trial
  • cell therapy
  • visible light
  • oxide nanoparticles
  • bone marrow